Literature DB >> 22885626

Risk factors associated with antihypertensive medication nonadherence in a statewide Medicaid population.

James E Bailey1, Mohammed Hajjar, Bushra Shoib, Jun Tang, Mario M Ray, Jim Y Wan.   

Abstract

BACKGROUND: This study seeks to determine the most important patient factors and health care exposures available through administrative databases associated with antihypertensive nonadherence.
METHODS: This is a cross-sectional analysis of Medicaid hypertensive patients of Tennessee enrolled for 3 to 7 years from 1994 to 2000. Demographic characteristics, comorbidity and health care utilization were assessed during a 2-year period. The primary outcome was antihypertensive medication refill nonadherence. Subjects were categorized as adherent or nonadherent using an 80% cutoff criteria. Associations with nonadherence were assessed using logistic regression modeling.
RESULTS: Of 49,479 subjects, 60.6% (n = 29,970) were classified as nonadherent and 39.4% (n = 19,509) as adherent. Significant predictors of nonadherence in multivariate analysis (P < 0.05) included male sex (odds ratio [OR] 1.12), black race (OR 1.67), urban residence (OR 1.12), obesity (OR 1.10), mental illness (OR 1.08) and substance abuse (OR 1.43). Significant protective factors included age (OR 0.97), disability (OR 0.62), diabetes (OR 0.76), hypercholesterolemia (OR 0.72) and Charlson index (OR 0.97). When health care utilization was considered, increased outpatient visits were associated with decreased nonadherence. Emergency department visits (OR 1.07) and hospital visits (OR 1.12) were associated with increased nonadherence.
CONCLUSIONS: This cross-sectional study suggests that substance abuse, black race, emergency department visits and hospitalizations are risk factors associated with nonadherence. Outpatient visits are associated with a small decrease in nonadherence. Further studies are needed to determine the characteristics of outpatient visits that most improve adherence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 22885626     DOI: 10.1097/MAJ.0b013e31825ce50f

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  17 in total

1.  Extended-release naltrexone for alcohol and opioid dependence: a meta-analysis of healthcare utilization studies.

Authors:  Daniel M Hartung; Dennis McCarty; Rongwei Fu; Katharina Wiest; Mady Chalk; David R Gastfriend
Journal:  J Subst Abuse Treat       Date:  2014-04-13

Review 2.  Factors associated with antihypertensive medication non-adherence: a systematic review.

Authors:  D M van der Laan; P J M Elders; C C L M Boons; J J Beckeringh; G Nijpels; J G Hugtenburg
Journal:  J Hum Hypertens       Date:  2017-06-29       Impact factor: 3.012

3.  Anti-Hypertensive Medication Use and Factors Related to Adherence Among Adults With Intellectual and Developmental Disabilities.

Authors:  Alissa C Cyrus; Julie Royer; Dianna D Carroll; Elizabeth A Courtney-Long; Suzanne McDermott; Margaret A Turk
Journal:  Am J Intellect Dev Disabil       Date:  2019-05

4.  Opioid analgesic misuse is associated with incomplete antiretroviral adherence in a cohort of HIV-infected indigent adults in San Francisco.

Authors:  Sara Jeevanjee; Joanne Penko; David Guzman; Christine Miaskowski; David R Bangsberg; Margot B Kushel
Journal:  AIDS Behav       Date:  2014-07

5.  Health coaching by medical assistants to improve control of diabetes, hypertension, and hyperlipidemia in low-income patients: a randomized controlled trial.

Authors:  Rachel Willard-Grace; Ellen H Chen; Danielle Hessler; Denise DeVore; Camille Prado; Thomas Bodenheimer; David H Thom
Journal:  Ann Fam Med       Date:  2015-03       Impact factor: 5.166

6.  Improving HCV cure rates in HIV-coinfected patients - a real-world perspective.

Authors:  Seetha Lakshmi; Maria Alcaide; Ana M Palacio; Mohammed Shaikhomer; Abigail L Alexander; Genevieve Gill-Wiehl; Aman Pandey; Kunal Patel; Dushyantha Jayaweera; Maria Del Pilar Hernandez
Journal:  Am J Manag Care       Date:  2016-05       Impact factor: 2.229

7.  Dynamic patterns and predictors of hydroxychloroquine nonadherence among Medicaid beneficiaries with systemic lupus erythematosus.

Authors:  Candace H Feldman; Jamie Collins; Zhi Zhang; S V Subramanian; Daniel H Solomon; Ichiro Kawachi; Karen H Costenbader
Journal:  Semin Arthritis Rheum       Date:  2018-01-08       Impact factor: 5.532

8.  Adherence of Elderly Patients with Cardiovascular Disease to Statins and the Risk of Exacerbation of Chronic Obstructive Pulmonary Disease: Evidence from an Italian Real-World Investigation.

Authors:  Federico Rea; Giulia Calusi; Matteo Franchi; Davide Liborio Vetrano; Giuseppe Roberto; Stefano Bonassi; Ursula Kirchmayer; Alessandro Chinellato; Alessandra Bettiol; Janet Sultana; Alessandro Mugelli; Giovanni Corrao
Journal:  Drugs Aging       Date:  2018-12       Impact factor: 3.923

9.  Sex differences in adherence to antihypertensive treatment in patients aged above 55: The French League Against Hypertension Survey (FLAHS).

Authors:  Mathilde Lefort; Lola Neufcourt; Bruno Pannier; Bernard Vaïsse; Sahar Bayat; Olivier Grimaud; Xavier Girerd
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-09-21       Impact factor: 3.738

10.  Implicit and Explicit Attitudes Toward Antihypertensive Medications Explain Variation in Pharmacy Refill and Self-Reported Adherence Beyond Traditional Risk Factors: Potential Novel Mechanism Underlying Adherence.

Authors:  Leslie S Craig; Erin Peacock; Brice L Mohundro; Julia H Silver; James Marsh; Taylor C Johnson; P Adam Kelly; Lydia A Bazzano; Michael Cunningham; Richard E Petty; Marie Krousel-Wood
Journal:  J Am Heart Assoc       Date:  2021-03-04       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.